Problem statement: Answer the multiple choice question.
Question: Which compound has a -61.685% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCC1=NN(C(=O)c2cccc([N+](=O)[O-])c2)C(O)(c2ccc(C)cc2)C1
b: Cc1cc(N2CC(C)OC(C)C2)n2cc(-c3ccccc3)nc2n1
Answer: b. Cc1cc(N2CC(C)OC(C)C2)n2cc(-c3ccccc3)nc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(N2CC(C)OC(C)C2)n2cc(-c3ccccc3)nc2n1
Cc1cc(N2CC(C)OC(C)C2)n2cc(-c3ccccc3)nc2n1
2,6-dimethyl-4-(7-methyl-2-phenylimidazo[1,2-a]pyrimidin-5-yl)morpholine